ASSOCIATION OF SERUM SOLUBLE ST2 AND INTERLEUKIN-33 WITH PRO-INFLAMMATORY CYTOKINES: A LINK BETWEEN ALLERGIC DISEASE AND INFLAMMATION

被引:0
|
作者
Sher, Janelle M. [1 ]
Littlefield, Michael [2 ]
Reiss, Allison B. [2 ]
Carsons, Steven [3 ]
Fonacier, Luz F. [1 ]
Voloshyna, Iryna [2 ]
机构
[1] Winthrop Univ Hosp, Sect Allergy & Clin Immunol, Mineola, NY 11501 USA
[2] Winthrop Univ Hosp, Winthrop Res Inst, Mineola, NY 11501 USA
[3] Winthrop Univ Hosp, Div Rheumatol Allergy & Immunol, Mineola, NY 11501 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:762 / 763
页数:2
相关论文
共 50 条
  • [21] Exploring the significance of interleukin-33/ST2 axis in minimal change disease
    Nobuhiro Kanazawa
    Masayuki Iyoda
    Taihei Suzuki
    Shohei Tachibana
    Ryuichi Nagashima
    Hirokazu Honda
    Scientific Reports, 13
  • [22] Predicting value of serum soluble ST2 and interleukin-33 for risk stratification and prognosis in patients with acute myocardial infarction
    ZHANG Kun
    ZHANG Xin-chao
    MI Yu-hong
    LIU Juan
    中华医学杂志(英文版), 2013, 126 (19) : 3628 - 3631
  • [23] Predicting value of serum soluble ST2 and interleukin-33 for risk stratification and prognosis in patients with acute myocardial infarction
    Zhang Kun
    Zhang Xin-chao
    Mi Yu-hong
    Liu Juan
    CHINESE MEDICAL JOURNAL, 2013, 126 (19) : 3628 - 3631
  • [24] Dysregulated Interleukin-33/ST2 Pathway Perpetuates Chronic Inflammation in Hashimoto's Thyroiditis
    Wang, Xuan
    Shao, Xiaoqing
    Liu, Xinhao
    Qin, Qiu
    Xu, Jian
    Zhang, Jin A.
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2019, 19 (07) : 1012 - 1021
  • [25] Interleukin-33/ST2 Axis as Potential Biomarker and Therapeutic Target in Kawasaki Disease
    Seigo Okada
    Hiroki Yasudo
    Yuji Ohnishi
    Chie Matsuguma
    Reiji Fukano
    Takahiro Motonaga
    Takako Waniishi
    Shunji Hasegawa
    Inflammation, 2023, 46 : 480 - 490
  • [26] INTERLEUKIN-33/ST2 AXIS IN PRIMARY SJOGREN'S SYNDROME: EXPRESSION IN SERUM AND SALIVARY GLAND, AND CLINICAL ASSOCIATION
    Jung, S. M.
    Kang, J. Y.
    Min, H. K.
    Koh, J. H.
    Suh, Y. S.
    Lee, J. H.
    Lee, J.
    Lee, J. Y.
    Kim, J. -M.
    Ju, J. H.
    Park, K. -S.
    Park, S. -H.
    Kim, H. -Y.
    Kwok, S. -K.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 194 - 195
  • [27] Interleukin-33/ST2 Axis as Potential Biomarker and Therapeutic Target in Kawasaki Disease
    Okada, Seigo
    Yasudo, Hiroki
    Ohnishi, Yuji
    Matsuguma, Chie
    Fukano, Reiji
    Motonaga, Takahiro
    Waniishi, Takako
    Hasegawa, Shunji
    INFLAMMATION, 2023, 46 (01) : 480 - 490
  • [28] Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension and their relationship with right ventricular structure and function
    Stanziola, Anna Agnese
    Carlomagno, Guido
    Vitale, Carolina
    Lanza, Maurizia
    Mercurio, Valentina
    Fazio, Serafino
    Sofia, Matteo
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [29] INTERLEUKIN-33 REGULATES THE DEVELOPMENT OF INFLAMMATORY BOWEL DISEASE THROUGH ITS RECEPTOR ST2 IN ENTERIC GLIAL CELLS
    Nie, Kai
    Yang, Yuanyuan
    Wang Xiaoyan
    GASTROENTEROLOGY, 2022, 162 (07) : S979 - S980
  • [30] Interleukin-33 and its receptor ST2 contribute to inflammation in the lungs of patients with idiopathic pulmonary fibrosis
    Pickering, Edward
    Todd, Nevins
    Lockatell, Virginia
    Atamas, Sergei
    Luzina, Irina
    JOURNAL OF IMMUNOLOGY, 2011, 186